Loading clinical trials...
Loading clinical trials...
The Role of Virtual Reality (VR) in Patient Experience When Used for Magnetic Resonance-Guided Radiation Therapy (MRgRT)
This clinical trial explores if using virtual reality (VR) headsets will help to improve patient understanding of their disease and decrease anxiety about treatment. Three-dimensional (3D) images may help the patient visualize their tumor and location better and therefore understand potential side effects. Visualizing a virtual representation of the magnetic resonance imaging (MRI) linear accelerator (Linac) may decrease treatment related anxiety.
PRIMARY OBJECTIVE: I. Examine patient reported comprehension of their tumor characteristics and treatment plan following 3D virtual reality review of their imaging. SECONDARY OBJECTIVE: I. Examine patient reported treatment related anxiety prior to and following virtual reality (VR) simulation of the MRI Linac treatment process. OUTLINE: Patients are assigned to 1 of 2 cohorts. COHORT I: Patients receive two-dimensional (2D) image review using standard computer screen on study. Patients undergo MRI and computed tomography (CT) imaging at screening and on study. COHORT II: Patients receive image review using virtual reality stimulation on study. Patients also view MRI treatment room using virtual reality stimulation. Patients undergo MRI and CT imaging at screening and on study.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Start Date
June 1, 2024
Primary Completion Date
January 1, 2025
Completion Date
February 1, 2025
Last Updated
May 15, 2025
Magnetic Resonance Imaging
PROCEDURE
Computed Tomography
PROCEDURE
Best Practice
OTHER
Questionnaire Administration
OTHER
Magnetic Resonance Imaging
PROCEDURE
Computed Tomography
PROCEDURE
Virtual Technology Intervention
OTHER
Questionnaire Administration
OTHER
Lead Sponsor
Thomas Jefferson University
NCT05039801
NCT04704661
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions